The previous page is sending you to https://www.newswire.ca/fr/news-releases/pfizer-canada-et-biontech-deposent-une-demande-en-continu-aupres-de-sante-canada-pour-le-vaccin-candidat-bnt162b2-contre-le-sras-cov-2-820587929.html.

 If you do not want to visit that page, you can return to the previous page.